No valuation for Congruence Therapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($136.5M) and the funding record below are the closest available signals.
- ·The complete investor list: 14 names
- ·Watch Congruence Therapeutics: the Monday email on marks, rounds and moves
Congruence Therapeutics funding history
No funding rounds for Congruence Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
How Congruence Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Congruence Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about Congruence Therapeutics
- How much has Congruence Therapeutics raised?
- Congruence Therapeutics has raised $136.5M in total funding across its recorded rounds.